Abstract
Increased ovarian or endometrial uptake may cause a dilemma in the interpretation of whole body F18-fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging or even misdiagnosis of malignant disease. Knowledge of benign FDG uptake of the ovaries and uterus is important for daily practice of nuclear medicine radiologists. Increased uptake in the ovaries or uterus indicates a pathologic or neoplastic process in postmenopausal patients. In premenopausal women, increased ovarian or endometrial uptake can be functional or malignant. Benign functional uptake of premenopausal ovaries or uterus is related to the menstrual cycle; therefore, information about the patient’s menstrual status is crucial for interpretation. In addition, correlation with computed tomography (CT), especially diagnostic CT acquired at the same time of PET/CT is very useful in clarifying the location of the uptake and the existence or disappearance of the discrete lesion. Increased ovarian uptake may also be identified in histologically different benign tumor entities. Nonmenstrual-related endometrial uptake may be present in many benign diseases as well.
Similar content being viewed by others
References
Rohren EM, Turkington TG, Coleman R. Clinical application of PET in oncology. Radiology 2004;231:302–332.
Fletecher JW, Djulbegovic B, Soares H, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008;49:480–508.
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT. J Nucl Med 2004:45:266–271.
Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging 2005;32:549–556.
Zhu Z, Wang B, Cheng W, Cheng X, Cui P, Huo L, et al. Endometrial and ovarian 18F-FDG uptake in serial PET studies and the value of delayed imaging for differentiation. Clin Nucl Med 2006;31:781–787.
Short S, Hoskin P, Wong W. Ovulation and increased FDG uptake on PET: potential for a false positive results. Clin Nucl Med 2005;30:707.
Cottrill HM, Fitzcharles EK, Modesitt SC. Positron emission tomography in a premenopausal asymptomatic woman: a case report of increased ovarian uptake in a benign condition. Int J Gynecol Cancer 2005;15:1127–1130.
Takanami K, Kaneta T, Niikura H, Kinomura S, Yamada S, Fukuda H, et al. Intense FDG uptake in the ovary with painless torsion. Clin Nucl Med 2007;32:805–806.
Ho KC, Ng KK, Yen TC, Chou HH. An ovary in luteal phase mimicking common iliac lymph node metastasis from a primary cutaneous peripheral primitive neuroectodermal tumor as revealed by 18F-FDG PET. Br J Radiol 2005;78:343–345.
Bagga S. A corpus luteal cyst masquerading as a lymph node mass on PET/CT scan in a pregnant woman with an anterior mediastinal lymphomatous mass. Clin Nucl Med 2007;32:649–651.
Fechel S, Grab D, Nuesle K, Kotzrke J, Rieber A, Kreienberg R, et al. Asymmetric adnexal masses: correlation of FDG PET and histopathologic findings. Radiology 2002;223:780–788.
Ames J, Blodgett T, Meltzer C. 18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false positive PET/CT in a patient with cervical carcinoma. AJR Am J Roentgenol 2005;185:1057–1059.
Kim SK, Kang KW, Roh JW, Sim JS, Lee ES, Park SY. Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging 2005;32:757–763.
Kol S, Ben-Shlomo I, Ruutiainen K, Ando M, Davies-Hill TM, Rohan RM, et al. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. J Clin Invest 1997;99:2274–2283.
Vanatier D, Dufour P, Tordjeman-Rizzi N, Prolongeau JF, Deepret-Moser S, Monnier JC. Immunological aspects of ovarian function: role of the cytokines. Eur J Obstet Gynecol Reprod Biol 1995;63:155–168.
Borders R, Breiman RS, Yeh BM, Qayyum A, Coakley FV. Computed tomography of corpus luteal cysts. J Comput Assist Tomogr 2004;28:340–342.
Smith MF, McIntush EW, Smith GW. Mechanism associated with corpus luteum development. J Anim Sci 1994;72:1857–1872.
Nishizawa S, Inubushi M, Ozawa F, Kido A, Okada H. Physiologic FDG uptake in the ovaries after hysterectomy. Ann Nucl Med 2007;21:345–348.
Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, et al. Diagnostic accuracy of 18F-FDG PET-CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasound, computed tomography and history. Nucl Med Commun 2007;28:589–595.
Frenchel S, Grab D, Nuessle K, Kotzerke J, Rieber A, Kreienberg R, et al. Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. Radiology 2002;223:780–788.
Rieber A, Nussle K, Stohr I, Grab D, Fenchel S, Kreienberg R, et al. Preoperative diagnosis of ovarian tumors with MR imaging. AJR Am J Roentgenol 2001;177:123–129.
Hubner KF, McDonald TW, Niethammer JG, Smith GT, Gould HR, Buonocore E. Assessment of primary and metastatic ovarian cancer by positron emission tomography using 2-[18F]deoxyglucose. Gynecol Oncol 1993;51:197–204.
Prabhakar H, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics 2007;27:145–159.
Wahl R. Why nearly all PET of abdominal and pelvic cancer will be performed as PET/CT. J Nucl Med 2004;45:82S–95S.
Chander S, Meltzer CC, McCook BM. Physiologic uterine uptake of FDG during menstruation demonstrated with serial combined positron emission tomography and computed tomography. Clin Nucl Med 2002;27:22–24.
Fujiwara T, Togashi K, Yamaoka T, Nakai A, Kido A, Noshio S, et al. Kinematics of the uterus: cine mode MR imaging. Radiographics 2004;24:e19.
Nakai A, Togashi K, Yamaoka T, Fujiwara T, Ueda H, Koyama T, et al. Uterine peristalsis shown on cine MR imaging using ultrafast sequence. J Magn Reson Imaging 2003;18:726–733.
Lobo RA, Stanczyk FZ. New knowledge in the physiology of hormonal contraceptives. Am J Obstet Gynecol 1994;170:1499–1507.
Julian A, Payoux P, Rimailho J, Paynot N, Esquerre J. Uterine uptake of 18F FDG on PET induced by an intrauterine device: unusual pitfalls. Clin Nucl Med 2007;32:128–129.
Breckenridge JW, Kurtz AB, Ritchie WGM, Macht EL. Postmenopausal uterine fluid collection: indicator of carcinoma. AJR 1982;139:529–534.
Imai A, Matsunami K, Ohno T, Tamaya T. Enhancement of growth-promoting activity in extract from uterine cancers by protein kinase C in human endometrial fibroblasts. Gynecol Obstet Invest 1992;33:109–113.
Koyama T, Tamai K, Togashi K. Staging of carcinoma of the uterine cervix and endometrium. Eur Radiol 2007;17:2009–2019.
Sahdev A, Reznek RH. Magnetic resonance imaging of endometrial and cervical cancer. Ann N Y Acad Sci 2008;1138:214–232.
Tsujikawa T, Yoshida Y, Mori T, Kurokawa T, Fujibayashi Y, Kotsuji F, et al. Uterine tumors: pathophysiologic imaging with 16a-F18-Fluoro-17b-estradiol and F18 Fluorodeoxyglucose PET-initial experience. Radiology 2008;248:599–605.
Lin CY, Ding HJ, Chen YK, Liu CS, Lin CC, Kao CH. 18F-FDG PET in detecting uterine leiomyoma. Clin Imaging 2008;32:38–41.
Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K. Standardized uptake values of uterine leiomyoma with 18FFDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI. Ann Nucl Med 2008;22:505–512.
Ak I, Ozalp S, Yalcin OT, Zor E, Vardareli E. Uptake of FDG in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography. Nucl Med Commun 2004;25:941–945.
Shida M, Murakami M, Tsukada H, Ishiguro Y, Kikuchi K, Yamashita E, et al. 18F-fluorodeoxyglucose uptake in leiomyomatous uterus. Int J Gynecol Cancer 2007;17:285–293.
Chura J, Truskinovsky AM, Judson PL, Johnson L, Geller M, Downs L Jr. Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review. Gynecol Oncol 2007;104:247–252.
Kao CH. FDG uptake in a huge uterine myoma. Clin Nucl Med 2003;28:249.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, Y. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med 23, 107–112 (2009). https://doi.org/10.1007/s12149-008-0227-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-008-0227-z